TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2012

Randomized phase II trial of erlotinib with and without entinostat in patients with advanced non-small-cell lung cancer who progressed on prior chemotherapy.

Samir E Witta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.